Journal
NATURE IMMUNOLOGY
Volume 14, Issue 9, Pages 908-+Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2665
Keywords
-
Categories
Funding
- Singapore Immunology Network of the Agency for Science, Technology and Research
- Swiss National Foundation
- Oncosuisse
- Wellcome Trust
- Medical Research Council Australia
- Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish
Ask authors/readers for more resources
Human T cells that express a T cell antigen receptor (TCR) containing g-chain variable region 9 and gamma-chain variable region 2 (V(gamma)9V(delta)2) recognize phosphorylated prenyl metabolites as antigens in the presence of antigen-presenting cells but independently of major histocompatibility complex (MHC), the MHC class I-related molecule MR1 and antigen-presenting CD1 molecules. Here we used genetic approaches to identify the molecule that binds and presents phosphorylated antigens. We found that the butyrophilin BTN3A1 bound phosphorylated antigens with low affinity, at a stoichiometry of 1:1, and stimulated mouse T cells with transgenic expression of a human V(gamma)9V(delta)2 TCR. The structures of the BTN3A1 distal domain in complex with host-or microbe-derived phosphorylated antigens had an immunoglobulin-like fold in which the antigens bound in a shallow pocket. Soluble V(gamma)9V(delta)2 TCR interacted specifically with BTN3A1-antigen complexes. Accordingly, BTN3A1 represents an antigen-presenting molecule required for the activation of V(gamma)9V(delta)2 T cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available